ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (603976) — Net Asset Quality Index
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (603976) has a Net Asset Quality Index of 62.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.95 Billion minus total liabilities of CN¥735.16 Million yields net assets of CN¥1.21 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check ChongQing Zhengchuan Pharmaceutical Pack liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 62.2%, representing net assets of CN¥1.21 Billion against total assets of CN¥1.95 Billion CNY. See ChongQing Zhengchuan Pharmaceutical Pack current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is ChongQing Zhengchuan Pharmaceutical Pack worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 63.4% | CN¥1.21 Billion | CN¥1.90 Billion | CN¥696.39 Million | ▲ +0.9 pp |
| 2024 | 62.5% | CN¥1.22 Billion | CN¥1.96 Billion | CN¥733.40 Million | ▲ +3.0 pp |
| 2023 | 59.5% | CN¥1.22 Billion | CN¥2.04 Billion | CN¥827.37 Million | ▲ +0.5 pp |
| 2022 | 59.0% | CN¥1.18 Billion | CN¥2.01 Billion | CN¥823.47 Million | ▼ -0.5 pp |
| 2021 | 59.5% | CN¥1.17 Billion | CN¥1.96 Billion | CN¥794.53 Million | ▼ -19.1 pp |
| 2020 | 78.5% | CN¥1.04 Billion | CN¥1.32 Billion | CN¥284.20 Million | ▼ -4.9 pp |
| 2019 | 83.5% | CN¥1.04 Billion | CN¥1.24 Billion | CN¥204.97 Million | ▼ -4.1 pp |
| 2018 | 87.6% | CN¥987.02 Million | CN¥1.13 Billion | CN¥139.44 Million | ▼ -2.2 pp |
| 2017 | 89.8% | CN¥953.93 Million | CN¥1.06 Billion | CN¥107.79 Million | ▲ +6.9 pp |
| 2016 | 82.9% | CN¥515.05 Million | CN¥621.05 Million | CN¥106.00 Million | ▼ -2.9 pp |
| 2015 | 85.9% | CN¥460.74 Million | CN¥536.55 Million | CN¥75.81 Million | ▼ -3.3 pp |
| 2014 | 89.1% | CN¥440.04 Million | CN¥493.67 Million | CN¥53.62 Million | ▼ -0.7 pp |
| 2013 | 89.8% | CN¥401.13 Million | CN¥446.67 Million | CN¥45.54 Million | — |